Clinical Programs

Boosted protease inhibitor regimens with 3TC work despite M184V resistance
September 21, 2009 | Aidsmap
People with HIV who have developed resistance to 3TC (lamivudine) can still achieve viral load suppression using boosted protease inhibitor regimens that include 3TC as part of the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) "backbone", researchers reported this week at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.
Experimental HIV drugs restore health of artist, many others
July 4, 2009 | Kelowna.com
It's been nearly five years since Vancouver artist Tiko Kerr reluctantly stepped into the national spotlight to become the modern face of AIDS in Canada.
A look at how Simon Fraser University and its people made news
April 24, 2009 | SFUnews
The Vancouver Sun told readers how three SFU researchers discovered exactly how extracts from a South Asian plant work to lower blood glucose levels in type-2 diabetics.
Drugs increase life expectancy of HIV patients by 13 years: study
August 1, 2008 | CBC
B.C. researcher Robert Hogg knew that a frequently used cocktail of drugs was helping people with HIV live longer than expected. He was also well aware of studies, regional in focus, that showed drugs taken in combination were keeping AIDS at bay.
Cocktail of drugs extends life of HIV patients
July 28, 2008 | News-Medical.net
According to Canadian researchers a cocktail which is a combination of HIV drugs can give AIDS patients an average of 13 years additional life.
Combination therapy increases HIV-infected patients' lifespan
July 25, 2008 | themoneytimes.com (India)
A team of UK researchers, led by Robert Hogg of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, suggested in their research Thursday that cocktails of HIV drugs help patients live an average of 13 years longer.
HIV-infected are not using drug cocktails
February 24, 2008 | The Province
Hundreds of people with HIV are dying without ever taking the drug cocktails that could prolong their lives for decades -- and those most at risk are the poor, the homeless, the mentally ill and the drug-addicted.
Many who died of HIV-AIDS hadn't taken free treatment
February 23, 2008 | The Record
Forty per cent of the people who died of HIV-AIDS in British Columbia never accessed life-saving treatment even though it was free, according to a new study released yesterday.
HIV study in B.C. finds many die without treatment
February 22, 2008 | The Canadian Press
Forty per cent of the people who died of HIV-AIDS in British Columbia never accessed life-saving treatment even though it was free, according to a new study released Friday.
Pharmacy data could be simple tool for monitoring HIV therapy
May 14, 2007 | The John Hopkins University Gazette
Pharmacy data can be used as a simple low-cost tool for monitoring a patient's adherence to HIV therapy in resource-limited areas, according to a study by researchers from the Johns Hopkins Bloomberg School of Public Health and other organizations.